Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.

Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE.

Neuropsychopharmacology. 2008 Feb;33(3):480-90. Epub 2007 Apr 18.

2.

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.

Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R.

Arch Gen Psychiatry. 2006 Jun;63(6):630-8.

PMID:
16754836
3.

A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia.

Postma P, Gray JA, Sharma T, Geyer M, Mehrotra R, Das M, Zachariah E, Hines M, Williams SC, Kumari V.

Psychopharmacology (Berl). 2006 Mar;184(3-4):589-99. Epub 2006 Feb 2.

PMID:
16456657
4.

Return to smoking following a smoke-free psychiatric hospitalization.

Prochaska JJ, Fletcher L, Hall SE, Hall SM.

Am J Addict. 2006 Jan-Feb;15(1):15-22.

PMID:
16449089
5.

Tobacco document research reporting.

Carter SM.

Tob Control. 2005 Dec;14(6):368-76. Review.

6.

Reduced cancer incidence among patients with schizophrenia.

Barak Y, Achiron A, Mandel M, Mirecki I, Aizenberg D.

Cancer. 2005 Dec 15;104(12):2817-21.

7.

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls.

Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, Lamberti S, D'Agostino RB, Stroup TS, Davis S, Lieberman JA.

Schizophr Res. 2005 Dec 1;80(1):45-53. Epub 2005 Sep 28.

PMID:
16198088
8.

Effects of nicotine nasal spray on cognitive function in schizophrenia.

Smith RC, Warner-Cohen J, Matute M, Butler E, Kelly E, Vaidhyanathaswamy S, Khan A.

Neuropsychopharmacology. 2006 Mar;31(3):637-43.

9.
10.

The whole truth and nothing but the truth? The research that Philip Morris did not want you to see.

Diethelm PA, Rielle JC, McKee M.

Lancet. 2005 Jul 2-8;366(9479):86-92.

PMID:
15993237
11.

A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.

Evins AE, Cather C, Deckersbach T, Freudenreich O, Culhane MA, Olm-Shipman CM, Henderson DC, Schoenfeld DA, Goff DC, Rigotti NA.

J Clin Psychopharmacol. 2005 Jun;25(3):218-25.

PMID:
15876899
12.

Nicotine analogues: a review of tobacco industry research interests.

Vagg R, Chapman S.

Addiction. 2005 May;100(5):701-12. Review.

PMID:
15847628
13.

Tobacco industry manipulation of research.

Bero LA.

Public Health Rep. 2005 Mar-Apr;120(2):200-8. Review. No abstract available.

14.

Prevalence of chronic obstructive pulmonary disease among those with serious mental illness.

Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L.

Am J Psychiatry. 2004 Dec;161(12):2317-9.

PMID:
15569908
15.

Treatment of tobacco use in an inpatient psychiatric setting.

Prochaska JJ, Gill P, Hall SM.

Psychiatr Serv. 2004 Nov;55(11):1265-70.

PMID:
15534015
16.

Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA.

Arch Gen Psychiatry. 2004 Nov;61(11):1107-15.

PMID:
15520358
17.

A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia.

Williams JM, Ziedonis DM, Foulds J.

Psychiatr Serv. 2004 Sep;55(9):1064-6.

PMID:
15345771
18.

Effects of nicotine on cognitive deficits in schizophrenia.

Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B, Zerbe G, Freedman R.

Neuropsychopharmacology. 2004 Jul;29(7):1378-85.

19.

Risk for cancer in parents of patients with schizophrenia.

Dalton SO, Laursen TM, Mellemkjaer L, Johansen C, Mortensen PB.

Am J Psychiatry. 2004 May;161(5):903-8.

PMID:
15121657
20.

Nicotine effects on brain function and functional connectivity in schizophrenia.

Jacobsen LK, D'Souza DC, Mencl WE, Pugh KR, Skudlarski P, Krystal JH.

Biol Psychiatry. 2004 Apr 15;55(8):850-8.

PMID:
15050867

Supplemental Content

Support Center